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entiation of both of them conﬁrmed by staining with Oil Red O and
Alizarin Red respectively. We carried out RT-PCR and immunohis-
tochemistry analysis to test expression of SOX9, type II collagen,
type I collagen and C-20 aggrecan which are proteoglycan com-
pounds of extra-cellular matrix and all of them were positive as
soon as after 4 days in culture. Expressions of type X collagen
and MMP-13 proteins also were measured raising their expression
as well as increase the time in culture.
Figure 1. COL1, COL2 and COLX gene expression by RT-PCR of spheroids
produced at 4, 7, 14, 28 and 46 days using our chondrogenic medium.
Conclusions: Join together our results strongly suggest that the
MSC pool from umbilical cord stromal tissue is an excellent source
of cells susceptible to differentiate to chondrocyte-like cells which
could be a new cellular therapy against cartilage degradation.
This work is supported by Xunta de Galicia (SERGAS Exp. PS 07
86)
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Purpose: To determine if the anti-osteoarthritis drug, pentosan
polysulfate (PPS), promoted proliferation and chondrogenic differ-
entiation of mesenchymal precursor stem cells (MPC) in vitro.
Methods: Human STRO-3+ MPC were maintained in monolayer
or micromass cultures (mmc) for up to 10 days in the absence
and presence of PPS at concentrations of 0.1, 0.5, 1.0, 2.5, 5.0,
10.0, and 20 μg/ml. MPC proliferation and viability was assessed
using the WST-1 mitochondral dehydrogenase cleavage assay
and by the incorporation of 3H-Thymidine into macromolecular
DNA in both culture systems. The capacity of PPS to protect
MPC from IL4/INF-γ induced apoptosis was also evaluated using
ﬂow cytometry. Proteoglycan (PG) biosynthesis was monitored
in mmc by the incorporation of 35SO4 into glycosaminoglycans
(35S-GAGs) on days 4, 5 and 6 post culture initiation. The relative
stimulatory effects of hyaluronan (HA) or dextran sulfate (DS)
on PG synthesis was also examined and compared to PPS in
day 5 mmc. The effects of PPS on the levels of bound and
unbound HA in MPC in mmc was quantiﬁed by an ELISA and
the deposition of type II collagen in the matrix assessed using
a COL-II Mab and immuno-staining of the ﬁxed cultures on day
10. The ability of PPS to modulate MPC osteogenic or adipogenic
differentiation was investigated by co-culturing the cells in the
respective inductive culture media for 28 days. Gene expression
by MPC in micromass cultures was determined on days 7 and 10
by Real Time and RT-PCR.
Results: On applying the WST-1 assay to day 6 monolayer cul-
tures it was found that PPS markedly stimulated MPC proliferation
with signiﬁcant effects being observed at concentrations of 1–10
μg/ml (p<0.01). However, DNA synthesis by MPC after 4 days
in mmc, showed a maximal stimulation by PPS at 1–2.5 μg/ml
(p<0.005). A 38% reduction in MPC apoptosis was obtained in the
presence of 1–10 μg/ml PPS. In 4–5 day MPC mmc, 5 μg/ml PPS
stimulated PG synthesis by 100% more than control (p<0.005)
while HA and DS at 5 μg/ml and greater inhibited PG synthesis
(p<0.005). In 10 day MPC mmc, PPS promoted maximal Type II
collagen deposition in the matrix at 5 μg/ml while maximal de-
position of HA, relative to controls, occurred with 20 μg/ml PPS
(p<0.005). The results of the bioassays examining cartilage matrix
production by MPC in the presence of PPS were supported by the
Real Time and RT-PCR gene expression studies using primers for
Aggrecan, COL-II, SOX-9 and other genes. Notably, while able to
stimulate chondrogenic differentiation of MPC, PPS at concentra-
tions in excess of 1.0 μg/ml inhibited osteogenic differentiation of
MPC (p<0.01).
Conclusions: These results conﬁrmed that PPS at low in-vitro
concentrations promoted early proliferation and chondrogenesis
of MPC while also blocking its potential to undergo osteogenic
differentiation. On the basis of the published literature and our
preliminary unpublished ﬁndings we propose that the promotion of
MPC chondrogenesis by PPS may be mediated by the ability of
this agent to enhance degradation of IGFBP-3 by ADAM-12s.
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Purpose: Osteoarthritis (OA) is a multifactorial disease charac-
terized by destruction of the articular cartilage due to environ-
mental, mechanical and genetic components. The genetics of OA
is complex and is not completely understood. Recent work has
demonstrated the importance of microRNAs (miRNAs) in carti-
lage function. MiRNAs are a class of small noncoding RNAs that
regulate gene expression and are involved in different cellular
process: apoptosis/proliferation, development, glucose and lipid
metabolism.
The aim of this study was identify and characterize the expres-
sion proﬁle of miRNAs in normal and OA chondrocytes and to
determine their role in the chondrocyte biology.
Methods: Chondrocytes were obtained from 1 healthy donor and
from 1 OA patient. After the ﬁrst passage, the cells were moved
to aggregate culture for a week. Evaluation of in vitro aggregate
culture was carried out using histochemical (hematoxylin-eosin,
Alcian Blue, Safranin O and Masson Tricromic) and immunohis-
tochemical (Aggrecan, Collagen Type I and II) stainings. MicroR-
NAs were extracted with miRVana Isolation kit and analyzed at
the CNIO Core Facilities (Madrid, Spain) using the Agilent Hu-
man miRNA Microarray. Raw microarray data were normalized
and analyzed using Agilent FeatureExtraction (FE) Software and
GeneSpring GX10. Of the 723 human miRNAs, a list of the differ-
entially expressed miRNAs in normal and OA chondrocytes was
bioinformatically analyzed (using Sanger miRBase, microRNA.org,
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miRNAMap and miRGen) combining gene expression information
with miRNA target prediction.
Results: We identiﬁed 7 up-regulated miRNA in both normal and
OA chondrocytes (miR-663, miR-638, miR-125b, miR-23a, miR-
23b, miR-103, miR-210) that through bioinformatic analysis could
be related with the chondrocyte phenotype and with the hypoxia
condition of the aggregate culture. In addition, 4 miRNA were up-
regulated in normal chondrocytes (miR-18a, miR-801, miR-370,
miR-224) and related with growth factors. Finally, 5 miRNA were
up-regulated in OA chondrocytes (miR-656, miR-138, miR-369-
3p, miR-143, miR-181d), related with inﬂammatory pathways and
transcription factors implicated in the regulation of chondrogenesis.
Conclusions: The data reported can be relevant to better under-
stand the molecular mechanism involved in the biology and in the
pathophysiology of the chondrocytes. This preliminary study could
help to improve the understanding of the pathogenesis of multi-
factorial diseases such as osteoarthritis and could have important
diagnostic and therapeutic potential.
Claudia Cicione was supported by a Fellowship from the University
of Rome “Sapienza”, Italy, now she is contract by Fundación Com-
plejo Hospitalario Universitario A Coruña, Spain. Emma Muiños
Lopez is beneﬁciary of a Fellowship from Rheumatology Spanish
Foundation, Spain. Silvia Diaz Prado is beneﬁciary of an Isidro
Parga Pondal contract from Xunta de Galicia, Spain.
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Purpose: Amniotic membranes have been used extensively as
biologic dressings in ophthalmic, abdominal, and plastic surgery.
Actually, there is growing evidence that the human amnion con-
tains various types of stem cell. Human amniotic membrane (HAM)
could be an alternative source to bone marrow. As amniotic mem-
brane is highly abundant and readily available, it has the potential
to be an important source of mesenchymal stem cells (MSCs)
with multilineage differentiation potential for human articular carti-
lage repair. Given the minimal ethical and legal issues associated
with its usage warrants further investigation into their functional
potential in vivo. The aim of thisstudy was investigate the poten-
tial of mesenchymal cells derived from HAM to differentiate into
chondrocytes, adipocytes and osteoblasts useful for regenerative
medicine and cell therapy.
Methods: Human amniotic membranes were obtained from
caesarean-sectioned mothers. Two different protocols of HAM
isolation were performed. After monolayer expansion of the ad-
herent cells, isolated from both protocols, we characterized them
by ﬂow citometry for MSC markers. Multipotentiality was studied
by means of the differentiation towards adipocytes, osteoblasts
and chondrocytes-like cells. Adipogenesis and osteogenesis were
induced using commercial medium (Lonza Group Ltd, Switzer-
land). Chondrogenesis was performed using cells in aggregate
culture and in a chondrogenic medium for 3 weeks. Histochemical
(hematoxylin-eosin, Masson’s thrichome, toluidine blue, safranin
O, Oil-Red-O, Alizarin Red), immunohistochemical (type II and I
collagens, aggrecan) and qPCR studies were performed in or-
der to evaluate the multilineage potential. For qPCR analysis the
following primers were used: Sox9, Agg and Col II (for chondro-
genesis), LPL, FABP4 and AMP1 (for adipogenesis), ALP and OC
(for osteogenesis).
Results: From each of the protocols we isolated two different pop-
ulations of mesenchymal cells derived from HAM. Both popula-
tions were characterized by the presence of the same cell surface
markers with the exception of CD44, CD73, CD105, CD166 and
CD117 markers. However, only one of the two populations had a
strong capacity to differentiate towards chondrocytes, adipocytes
and osteoblast. In this population, after 21 days of culture, the
differentiations showed to be consistent and were conﬁrmed by
qPCR analysis.
Conclusions: We isolated a high pluripotency mesenchymal stem
cell population from HAM, suggesting that they may be very useful
to repair articular cartilage injuries and to improve the under-
standing of the molecular events implicated in chondrogenesis.
Further studies should be carried out to determine whether such
in vitro-differentiated cells can function in vivo.
Project funded by Servizo Galego de Saúde (SERGAS), Xunta de
Galicia (PS07/84) and Instituto de Salud Carlos III CIBER BBN
CB06-01-0040. Claudia Cicione was supported by a Fellowship
from the University of Rome “Sapienza”, Italy, now she is con-
tract by Fundación Complejo Hospitalario Universitario A Coruña,
Spain. Emma Muiños Lopez is beneﬁciary of a Fellowship from
Rheumatology Spanish Foundation, Spain. Silvia Diaz Prado is
beneﬁciary of an Isidro Parga Pondal contract from Xunta de
Galicia, Spain.
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AND IN VIVO
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Purpose: The aim of this study is to evaluate the effect of low-
intensity pulsed ultrasound (LIPUS) for scaffold-free chondrocyte
plate in vitro and in vivo.
Methods: Chondrocytes were collected from articular cartilage of
Japanese white rabbits. For acquirement the number of cells, the
collected primary chondrocytes (passage 0, P0) were cultured up
to subconﬂuent in 500cm2 square dishes. The cells were then
condensed to the density at 107cells/cm2 (passage 1, P1) on
synthetic membranes with 0.2μm pore. The LIPUS application
group was stimulated for 20 min/day. The mode of the applied
ultrasound is a 200μs burst sine wave of 1.5 MHz repeating
at 1kHz with an intensity of 30mW/cm2. To investigate effect
LIPUS stimulation on the matrix-synthesis of the constructs, mRNA
expression of type II collagen (col2), aggrecan and typeIcollagen
(col1) was studied using real-time polymerase chain reaction.
Synthesis of type II collagen and proteoglycan was also assessed
histochemically. We made full-thickness cartilage defect model in
rabbit and tried to repair full thickness cartilage defect with allograft
of the chondrocyte plate, and assessed histochemically.
Results: In our previous study, we presented that high-density
culture with P1 chondrocytes more than 107cells/cm2 could form
a cell mass as scaffold-free cartilage under existing cell-cell inter-
actions in rat model.
In this way, the chondrocytes (P1) prepared at 107cells/cm2 de-
tached from the membranes to form a plate of chondrocytes
around the 7th day (day 7) of starting P1 culture. After forming the
plate, the constructs were detached then by surgical pincers and
moved to simple 6 well dishes for oxygen and nutrition diffusion.
The expression of col2 and aggrecan mRNA was signiﬁcantly
higher in the group by stimulation of LIPUS (LIPUS group) than
the group by no stimulation (sham group).
